Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis

BACKGROUND: For research with human participants to be ethical, risk must be in a favorable balance with potential benefits. Little is known about the risk/benefit ratio for pediatric cancer phase II trials testing targeted therapies. OBJECTIVE: Our aim was to conduct a systematic review of prelimin...

Descripción completa

Detalles Bibliográficos
Autores principales: Strzebonska, Karolina, Wasylewski, Mateusz T., Zaborowska, Lucja, Polak, Maciej, Slugocka, Emilia, Stras, Jakub, Blukacz, Mateusz, Gyawali, Bishal, Waligora, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266705/
https://www.ncbi.nlm.nih.gov/pubmed/34110559
http://dx.doi.org/10.1007/s11523-021-00822-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266705/
https://www.ncbi.nlm.nih.gov/pubmed/34110559
http://dx.doi.org/10.1007/s11523-021-00822-5

Ejemplares similares